SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-15-001446
Filing Date
2015-03-10
Accepted
2015-03-09 18:05:03
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K imuc-10k_20141231.htm 10-K 1766487
2 EX-23.1 imuc-ex231_201412316.htm EX-23.1 2926
3 EX-31.1 imuc-ex311_201412317.htm EX-31.1 15782
4 EX-31.2 imuc-ex312_201412318.htm EX-31.2 15890
5 EX-32.1 imuc-ex321_201412319.htm EX-32.1 9233
6 EX-32.2 imuc-ex322_2014123111.htm EX-32.2 8775
  Complete submission text file 0001564590-15-001446.txt   7454608

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT imuc-20141231.xml EX-101.INS 969222
8 XBRL TAXONOMY EXTENSION SCHEMA imuc-20141231.xsd EX-101.SCH 51314
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imuc-20141231_cal.xml EX-101.CAL 39019
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imuc-20141231_def.xml EX-101.DEF 126311
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE imuc-20141231_lab.xml EX-101.LAB 358851
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imuc-20141231_pre.xml EX-101.PRE 257729
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

IRS No.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35560 | Film No.: 15686444
SIC: 2834 Pharmaceutical Preparations